New Powers For Australian Agency To Deal With Drug Shortages
Measures just introduced by the Therapeutic Goods Administration are intended to ensure the ongoing and reliable supply of important medicines and to improve the information in the drug shortages database.
You may also be interested in...
The TGA has taken a series of actions to address supply chain issues, including on the regulatory front, but it says more remains to be done and is asking stakeholders for suggestions in a new online survey.
Australia’s health department has issued guidance giving more details of the requirement to hold minimum levels of stocks of specified medicines from mid-2023.
A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.